- Home
- CHD vs GH Comparison
CHD vs GH Comparison
Compare CHD & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHD | GH |
|---|---|---|
| Founded | 1846 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.4B | 20.6B |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CHD | GH |
|---|---|---|
| Price | $103.19 | $168.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 19 |
| Target Price | $102.18 | ★ $119.79 |
| AVG Volume (30 Days) | 1.5M | ★ 2.0M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.28% | N/A |
| EPS Growth | ★ 27.43 | 6.74 |
| EPS | ★ 1.76 | N/A |
| Revenue | ★ $6,203,200,000.00 | $982,021,000.00 |
| Revenue This Year | $0.25 | $33.30 |
| Revenue Next Year | $3.65 | $28.27 |
| P/E Ratio | $58.66 | ★ N/A |
| Revenue Growth | 1.57 | ★ 32.88 |
| 52 Week Low | $81.33 | $53.40 |
| 52 Week High | $106.04 | $176.58 |
Technical Indicators
Market Signals| Indicator | CHD | GH |
|---|---|---|
| Relative Strength Index (RSI) | 63.06 | 63.23 |
| Support Level | $92.26 | $94.02 |
| Resistance Level | $106.04 | $175.33 |
| Average True Range (ATR) | 2.28 | 7.63 |
| MACD | 0.53 | 0.97 |
| Stochastic Oscillator | 88.12 | 76.56 |
Price Performance
Historical ComparisonAbout CHD Church & Dwight Company Inc.
Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its brands also include Batiste, OxiClean, Vitafusion, Hero, and TheraBreath, which, together with Arm & Hammer, account for around 70% of its annual sales and profits. Most recently, the firm added Touchland and its hand sanitizer business to its fold. Even as it works to expand its product reach, Church & Dwight still derives around 80% of its sales from its home market in the US.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.